OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
Vanessa E. Kennedy, Cecelia Perkins, Andreas Reiter, et al.
Blood Advances (2022) Vol. 7, Iss. 9, pp. 1713-1724
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
Animesh Pardanani
American Journal of Hematology (2023) Vol. 98, Iss. 7, pp. 1097-1116
Open Access | Times Cited: 60

The international consensus classification of eosinophilic disorders and systemic mastocytosis
Sa A. Wang, Attilio Orazi, Jason Gotlib, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1286-1306
Closed Access | Times Cited: 28

Mast Cell Leukemia: An Update with a Practical Review
Magda Zanelli, Martina Quintini, Salvatore Magnasco, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1664-1664
Open Access | Times Cited: 11

Mast cell leukemia: a rare case report and literature review
Lu Tian, Xiang Yan, Shaodan Tian, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

Case report: Experience of a rare case of primary acute mast cell leukemia
Zhijuan Pan, Ying Zhang, Yanru Guo, et al.
Leukemia Research Reports (2025), pp. 100510-100510
Open Access

Mastocytosis
Cem Akin, Michel Arock, Melody C. Carter, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access

Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM
Peter Valent, Karin Hartmann, Gregor Hoermann, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 12, pp. 3250-3260.e5
Open Access | Times Cited: 3

KIT Mutations and Other Genetic Defects in Mastocytosis
Yannick Chantran, Peter Valent, Michel Arock
Immunology and Allergy Clinics of North America (2023) Vol. 43, Iss. 4, pp. 651-664
Open Access | Times Cited: 8

Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis
Nicole Naumann, Martina Rudelius, Johannes Lübke, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 593-593
Open Access | Times Cited: 2

European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 6, pp. 1706-1717
Open Access | Times Cited: 5

Drug delivery targets and strategies to address mast cell diseases
Clayton H. Rische, Ariel Helms Thames, Rebecca A. Krier-Burris, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 2, pp. 205-222
Open Access | Times Cited: 4

Recent advances in diagnosis and therapy in systemic mastocytosis
Hyun Jung Lee
Blood Research (2023) Vol. 58, Iss. S1, pp. S96-S108
Open Access | Times Cited: 4

Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome
Animesh Pardanani, Ayalew Tefferi, Aref Al‐Kali, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 1
Open Access | Times Cited: 4

Renal Extramedullary Hematopoiesis in Mast Cell Leukemia with Bone Marrow Fibrosis
Damian Rieke, Laura K. Schmalbrock, Jana Ihlow, et al.
Case Reports in Hematology (2024) Vol. 2024, pp. 1-6
Open Access | Times Cited: 1

Advanced systemic mastocytosis—Revised classification, new drugs and how we treat
Animesh Pardanani, Kaaren K. Reichard, Ayalew Tefferi
British Journal of Haematology (2023) Vol. 204, Iss. 2, pp. 402-414
Closed Access | Times Cited: 2

Nouveaux critères diagnostiques des mastocytoses : des progrès mais encore des interrogations
Michel Arock
Bulletin de l Académie Nationale de Médecine (2024) Vol. 208, Iss. 6, pp. 810-823
Closed Access

SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis
Helen T. Chifotides, Prithviraj Bose
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access

Treatment refractory mast cell leukemia with dominant gastrointestinal manifestation and concomitant skin symptoms: A case report
M Wysocki, Maciej Gonciarz, Bartosz Puła
World Journal of Clinical Cases (2024) Vol. 12, Iss. 20, pp. 4317-4324
Open Access

Acute Mast Cell Leukemia With Complex Karyomorphism and Karyotypes
S M Li, Yantian Zhao
International Journal of Laboratory Hematology (2024)
Closed Access

Transcriptomic profiling does not refine mastocytosis diagnosis
Lars Buschhorn, Dorett I. Odoni, Johanna Geuder, et al.
Haematologica (2023) Vol. 108, Iss. 11, pp. 3125-3130
Open Access

Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms
Tsewang Tashi, Michael W. Deininger
Immunology and Allergy Clinics of North America (2023) Vol. 43, Iss. 4, pp. 723-741
Closed Access

Mast cell leukemia associated with essential thrombocythemia: a type of MCL-AHN (MCL-AMN)
Magda Zanelli, Francesca Sanguedolce, Maurizio Zizzo, et al.
Annals of Hematology (2023) Vol. 102, Iss. 9, pp. 2621-2623
Closed Access

Page 1 - Next Page

Scroll to top